A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC) Read more about A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma Read more about Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection Read more about Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection
The Tether™ - Vertebral Body Tethering System Post Approval Study Read more about The Tether™ - Vertebral Body Tethering System Post Approval Study
Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa Read more about Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa
Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome Read more about Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome
Registry of Asthma Patients Initiating DUPIXENT® Read more about Registry of Asthma Patients Initiating DUPIXENT®
Actigraphy Improvement With Voxelotor (ActIVe) Study Read more about Actigraphy Improvement With Voxelotor (ActIVe) Study
A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060) Read more about A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19) Read more about Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)